Efficiency of First‐Trimester Uterine Artery Doppler, A‐Disintegrin and Metalloprotease 12, Pregnancy‐Associated Plasma Protein A, and Maternal Characteristics in the Prediction of Preeclampsia
Open Access
- 1 September 2013
- journal article
- research article
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 32 (9) , 1593-1600
Abstract
Objectives: The purpose of this study was to estimate the efficiency of first‐trimester uterine artery Doppler, A‐disintegrin and metalloprotease 12 (ADAM12), pregnancy‐associated plasma protein A (PAPP‐A), and maternal characteristics in the prediction of preeclampsia.Methods: We conducted a prospective cohort study of patients presenting for first‐trimester aneuploidy screening between 11 and 14 weeks' gestation. Maternal serum ADAM12 and PAPP‐A levels were measured by an immunoassay, and mean uterine artery Doppler pulsatility indices were calculated. Outcomes of interest included preeclampsia, early preeclampsia (defined as requiring delivery at U statistics.Results: Among 578 patients with complete outcome data, there were 54 cases of preeclampsia (9.3%) and 13 cases of early preeclampsia (2.2%). Median ADAM12 levels were significantly lower in patients who developed preeclampsia compared to those who did not (0.81 versus 1.01 MoM; P = .04). For a fixed false‐positive rate of 10%, ADAM12, PAPP‐A, and uterine artery Doppler parameters in combination with maternal characteristics identified 50%, 48%, and 52% of patients who developed preeclampsia, respectively. Combining these first‐trimester parameters did not improve the predictive efficiency of the models.Conclusions: First‐trimester ADAM12, PAPP‐A, and uterine artery Doppler characteristics are not sufficiently predictive of preeclampsia. Combinations of these parameters do not further improve their screening efficiency.Keywords
Funding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (5 T32 HD055172)
This publication has 20 references indexed in Scilit:
- Predicting the risk of pre‐eclampsia between 11 and 13 weeks' gestation by combining maternal characteristics and serum analytes, PAPP‐A and free β‐hCGPrenatal Diagnosis, 2010
- First-Trimester Maternal Serum a Disintegrin and Metalloprotease 12 (ADAM12) and Adverse Pregnancy OutcomeObstetrics & Gynecology, 2008
- First‐trimester uterine artery Doppler indices in term and preterm pre‐eclampsiaUltrasound in Obstetrics & Gynecology, 2008
- ADAM12s in maternal serum as a potential marker of pre‐eclampsiaPrenatal Diagnosis, 2008
- Screening for pre‐eclampsia and fetal growth restriction by uterine artery Doppler and PAPP‐A at 11–14 weeks' gestationUltrasound in Obstetrics & Gynecology, 2007
- Bilateral notching of uterine arteries at 12–14 weeks of gestation for prediction of hypertensive disorders of pregnancyActa Obstetricia et Gynecologica Scandinavica, 2005
- Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunctionAmerican Journal of Obstetrics and Gynecology, 2005
- Uterine artery Doppler at 11–14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected populationUltrasound in Obstetrics & Gynecology, 2005
- First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial)American Journal of Obstetrics and Gynecology, 2004
- ADAM 12-S Cleaves IGFBP-3 and IGFBP-5 and Is Inhibited by TIMP-3Biochemical and Biophysical Research Communications, 2000